Friday, July 10, 2026

Intelligence · INN directory

Neurology Drugs Directory

Central nervous system therapies — Alzheimer's, Parkinson's, epilepsy, migraine, and neurology pipeline programs.

Drugs in segment 2
Companies 1,771
Pipeline programs 20,548

Quick answer

Neurology & CNS drugs: NovaPharmaNews indexes 2 pharmaceutical drugs in this therapeutic segment with regulatory status, pipeline programs, patents, and congress coverage cross-links. Central nervous system therapies — Alzheimer's, Parkinson's, epilepsy, migraine, and neurology pipeline programs.

2 drugs · Neurology & CNS drugs · by data quality

  1. phenobarbitone sodium (may only be prescribed for the treatment of epilepsy)

    NULL

    TGA: approved

  2. alzheimer

    NMPA: clinical trials

Frequently asked questions

How many neurology & cns drugs are in the directory?

2 drug profiles match this therapeutic area filter based on class, mechanism, target, and INN metadata.

How are drugs assigned to a therapeutic area?

Classification uses WHO therapeutic class, mechanism of action, molecular target, and INN pattern matching against curated oncology, metabolic, CNS, rare disease, and immunology taxonomies.

Where does regulatory data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence.